Search research articles
Contact Us
Filters
Showing results (91-100 of 139) with videos related to
Page
of 14
Sort By:
Clinical Science (London, England : 1979)
|
November 3, 2016
Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis
François Cauchy, Mouniya Mebarki, Benjamin Leporq, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells
Katherine S Lovejoy, Maria Serova, Ivan Bieche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 2, 2018
Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1
Denis Soulières, Lisa Licitra, Ricard Mesía, et al.
Frontiers in Chemistry
|
May 14, 2014
Cancer wars: natural products strike back
Christine Basmadjian, Qian Zhao, Embarek Bentouhami, et al.
Pancreas
|
December 14, 2011
Biological and prognostic relevance of mitogen-activated protein kinases in pancreatic adenocarcinoma
Adriana Handra-Luca, Claude Lesty, Pascal Hammel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
Molecular detection of early-stage laryngopharyngeal squamous cell carcinomas
Stephane Temam, Jean Bénard, Christelle Dugas, et al.
Investigational New Drugs
|
January 8, 2014
Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies
Francois Goldwasser, Sandrine Faivre, Jerome Alexandre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
Sandrine Faivre, Catherine Delbaldo, Karina Vera, et al.
Oral Oncology
|
July 11, 2012
Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue
Sébastien Albert, Muriel Hourseau, Caroline Halimi, et al.
Acta Oncologica (Stockholm, Sweden)
|
June 23, 2016
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers
Sihem Sebbagh, Julia Roux, Chantal Dreyer, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 139) with videos related to
Sort By:
Page
of 14
Clinical Science (London, England : 1979)
|
November 3, 2016
Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis
François Cauchy, Mouniya Mebarki, Benjamin Leporq, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells
Katherine S Lovejoy, Maria Serova, Ivan Bieche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 2, 2018
Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1
Denis Soulières, Lisa Licitra, Ricard Mesía, et al.
Frontiers in Chemistry
|
May 14, 2014
Cancer wars: natural products strike back
Christine Basmadjian, Qian Zhao, Embarek Bentouhami, et al.
Pancreas
|
December 14, 2011
Biological and prognostic relevance of mitogen-activated protein kinases in pancreatic adenocarcinoma
Adriana Handra-Luca, Claude Lesty, Pascal Hammel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
Molecular detection of early-stage laryngopharyngeal squamous cell carcinomas
Stephane Temam, Jean Bénard, Christelle Dugas, et al.
Investigational New Drugs
|
January 8, 2014
Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies
Francois Goldwasser, Sandrine Faivre, Jerome Alexandre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
Sandrine Faivre, Catherine Delbaldo, Karina Vera, et al.
Oral Oncology
|
July 11, 2012
Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue
Sébastien Albert, Muriel Hourseau, Caroline Halimi, et al.
Acta Oncologica (Stockholm, Sweden)
|
June 23, 2016
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers
Sihem Sebbagh, Julia Roux, Chantal Dreyer, et al.
Page
of 14